Samsung Biologics Co.,Ltd.

Research Samsung Biologics Co.,Ltd. (207940) on Bullrun: market cap KRW 64.39T. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker207940
• ExchangeKS
• CountrySouth Korea
• SectorHealthcare
• IndustryBiotechnology
• CurrencyKRW
• Market capKRW 64.39T
• Financial periodQ1 2026
• RevenueKRW 1.26T
• Net incomeKRW 469.25B
• Free cash flowKRW 676.16B
• Gross margin54.1%

Valuation Snapshot

latest market cap is KRW 64.39T.

About Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services;

Frequently asked questions

What is Samsung Biologics Co.,Ltd.'s market cap?

Samsung Biologics Co.,Ltd.'s market capitalization is KRW 64.39T.

What does Samsung Biologics Co.,Ltd. do?

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.